ホーム › 大うつ病性障害 › ペンシルベニア › Philadelphia
Philadelphia、PAにおける大うつ病性障害の臨床試験
Philadelphiaとその周辺地域（約30マイル以内）の拠点で、大うつ病性障害に関する23件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
被験者募集中第3相
- Adams Clinical Philadelphia, Philadelphia
- Flourish Research Philadelphia, Philadelphia
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
被験者募集中第3相
- Adams Clinical Philadelphia, Philadelphia
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
被験者募集中第3相
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester · 24マイル先
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
被験者募集中第3相
- Adams Clinical Philadelphia, Philadelphia
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- Suburban Research Associates, West Chester · 24マイル先
Precision Depression Adalimumab Trial
被験者募集中第2相
- University of Pennsylvania, Philadelphia
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
被験者募集中第3相
- University of Pennsylvania - Perelman School of Medicine, Philadelphia
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
被験者募集中第3相
- University of Pennsylvania, Philadelphia
Pilot Study: Establishing Glutamatergic Changes in Rapid Antidepressant Effects of Ketamine
被験者募集中早期第1相
- University of Pennsylvania, Philadelphia
Decoding and Modulating Affective Brain States
被験者募集中参加者への支払いあり
- University of Pennsylvania, Philadelphia
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
被験者募集中第2相
- Draig Clinical Site, Media · 12マイル先
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
被験者募集中
- Pennsylvania Hospital, Philadelphia
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
被験者募集中第2相
- Draig Clinical Site, Media · 12マイル先
Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression
被験者募集中第3相
- Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Philadelphia
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
被験者募集中第3相
- Adams Clinical - Philadelphia, Philadelphia
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
被験者募集中第2相
- Adams Clinical, Philadelphia
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Philadelphia
A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
被験者募集中第3相
- Neurocrine Clinical Site, Philadelphia
Triage Survey for Psychiatry Research Eligibility
被験者募集中観察研究
- Adams Clinical, Philadelphia, Philadelphia
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
被験者募集中第2相
- University of Pennsylvania, Philadelphia
Taking Action for College Students
被験者募集中
- Temple University, Philadelphia
Neurofeedback to Treat Depression - 2
被験者募集中
- Center for Neuromodulation in Depression and Stress, Philadelphia
他の都市における大うつ病性障害の試験
- New York City, NY36件の研究
- Boston, MA31件の研究
- Atlanta, GA25件の研究
- Orlando, FL19件の研究
- Miami, FL18件の研究
- Chicago, IL17件の研究
- Tampa, FL17件の研究
- San Diego, CA16件の研究
- Houston, TX16件の研究
- Little Rock, AR14件の研究
- Austin, TX13件の研究
- Las Vegas, NV13件の研究
Philadelphiaにおける他の研究
- がん（全種類）59件の研究
- 乳がん56件の研究
- 非小細胞肺癌51件の研究
- 転移性癌46件の研究
- 前立腺がん44件の研究
- 大腸癌44件の研究
- 卵巣がん44件の研究
- 肺がん36件の研究
- 急性骨髄性白血病34件の研究
- 心不全31件の研究
- 子宮内膜がん28件の研究
- うつ病26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。